Cellectis (CLLS) Enterprise Value (2013 - 2026)

Cellectis' Enterprise Value history runs 14 years deep, the most recent figure standing at -$185.7 million for Q1 2026.

• On a quarterly basis, Enterprise Value rose 23.81% year-over-year to -$185.7 million in Q1 2026; TTM through Mar 2026 was -$185.7 million, a 23.81% increase from a year earlier, with the FY2025 full-year figure at -$208.7 million, up 19.84% from the prior year.
• Enterprise Value improved to -$185.7 million in Q1 2026 per CLLS's latest filing, from -$208.7 million in the prior quarter.
• Across five years, Enterprise Value topped out at -$67.4 million in Q3 2023 and bottomed at -$345.2 million in Q4 2023.
• The 5-year median for Enterprise Value is -$192.2 million (2025), against an average of -$182.6 million.
• Across the five-year window, Enterprise Value surged 45.51% in 2022 and sank 287.4% in 2024, its largest moves.
• Year by year, Enterprise Value stood at -$93.1 million in 2022, then tumbled by 270.56% to -$345.2 million in 2023, then rose by 24.59% to -$260.3 million in 2024, then advanced by 19.84% to -$208.7 million in 2025, then climbed by 11.02% to -$185.7 million in 2026.
• Per Business Quant, the three latest CLLS Enterprise Value figures stand at -$185.7 million (Q1 2026), -$208.7 million (Q4 2025), and -$192.2 million (Q3 2025).